In another recent multicenter retrospective study, Borghetti et al. evaluated the outcomes of 106 NSCLC patients with EGFR mutations and ALK rearrangements treated with radiotherapy concomitant to TKI. Here, ALK is linked to non-small cell lung carcinoma.